Results 251 to 260 of about 46,906 (308)

[Current classification of anti-arrhythmia agents].

Zeitschrift fur Kardiologie, 2000
Antiarrhythmic drugs can be divided into four Vaughan Williams classes (I-IV) according to defined electrophysiological effects on the myocardium. Thus, the Vaughan Williams classification also coincides with the main myocardial targets of the antiarrhythmics, i.e., myocardial sodium-, potassium-, and calcium-channels or beta-adrenergic receptors.
J, Weirich, W, Wenzel
openaire   +1 more source

[Proarrhythmic effects of anti-arrhythmia agents].

La Revue de medecine interne, 1995
Antiarrhythmic medications are widely used either at the ventricular or supraventricular level. However, those drugs can induce severe side effects. Actually, antiarrhythmic drugs are paradoxically able to favour the occurrence of new arrhythmias or aggravate the preexisting arrhythmia for which they were indicated.
P, Scanu, D, Agostini, G, Grollier, A, Belin, B, Valette, J C, Potier   +5 more
openaire   +1 more source

[Propafenone--a promising anti-arrhythmia agent?].

Sbornik vedeckych praci Lekarske fakulty Karlovy univerzity v Hradci Kralove. Supplementum, 1991
Propafenone hydrochloride (Rytmonorm, Prolekofen) belongs to the membranous anti-arrhythmical agents of IC group. Simultaneously, it produces a mild beta blocking effect and blocks slow Calcium channels. The mentioned agent is of current use in treating both the supraventricular and ventricular tachyarrhythmias.
openaire   +1 more source

Anti-arrhythmia agents.

La Clinica terapeutica, 1977
G, Bracchi, F, Vezzoli
openaire   +1 more source

[Arrhythmogenic anti-arrhythmia agents].

Cardiology, 1983
H, Löllgen, M H, Hust, K, Nitsche, H, Wollschläger, T, Bonzel, H, Just   +5 more
openaire   +1 more source

[Ventricular cardiac arrhythmias. New anti-arrhythmia agents].

Zeitschrift fur Kardiologie, 1997
The CAST studies have shown that class I antiarrhythmic agents cause an increase in mortality in patients with ventricular tachyarrhythmias after myocardial infarction. This led to an increase in the use of class III agents. The most important class III antiarrhythmic substances are amiodarone and sotalol.
openaire   +1 more source

[Modern anti-arrhythmia drug agents].

Meditsinskaia sestra, 1991
Kh Kh, Shugushev, S N, Bogaeva
openaire   +1 more source

[USE OF ANTI-ARRHYTHMIA AGENTS].

[Sogo rinsho] Clinic all-round, 1996
N, KIMURA, T, WADA
openaire   +1 more source

[Selection of anti-arrhythmia agents].

Nihon rinsho. Japanese journal of clinical medicine, 1983
H, Kasanuki, K, Hirosawa
openaire   +1 more source

Cancer Chemotherapeutic Agents

Ca-A Cancer Journal for Clinicians, 1981
exaly   +2 more sources